M. Stumm

发表

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.

Christine Stephan, Michael Stumm, Cathrin Brisken, 2008, Cancer research.

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Kam Y. J. Zhang, K. Flaherty, J. Sosman, 2010, Nature.

The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.

W. König, M. Stumm, C. Philipp, 1999, Anticancer research.

In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide.

M. V. D. Kooij, M. A. van der Kooij, M. Stumm, 2001, Journal of hepatology.

Beta1 integrins regulate myoblast fusion and sarcomere assembly.

U. Müller, J. Schittny, O. Dorchies, 2003, Developmental cell.

Fate of undifferentiated mouse embryonic stem cells within the rat heart: role of myocardial infarction and immune suppression

E. Bettiol, P. Zammaretti, M. Dubois‐Dauphin, 2008, Journal of cellular and molecular medicine.

Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats.

J. Reichen, M. Stumm, C. Sieber, 2002, Liver.

Increased angiogenesis in portal hypertensive rats: Role of nitric oxide

M. Stumm, C. Sieber, E. Battegay, 1999, Hepatology.

Accurate gene expression measurement in formalin-fixed and paraffin-embedded tumor tissue.

M. Stumm, C. Sieber, D. D'orazio, 2002, The American journal of pathology.

Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis

H. Lane, D. Kwiatkowski, Kristen N. Pollizzi, 2009, Molecular Cancer.

Expression of mRNA for ROS-generating NADPH oxidases in the aging stomach

K. Krause, F. Herrmann, I. Szanto, 2005, Experimental Gerontology.

Molecular pharmacodynamic (MPD) evaluation of dose and schedule of RAD001 (everolimus) in patients with operable prostate carcinoma (PC)

T. Roskams, S. Dimitrijević, E. Lerut, 2005 .

Inhibition of NO Biosynthesis, but not Elevated Blood Pressure, Reduces Angiogenesis in Rat Models of Secondary Hypertension

M. V. D. Kooij, M. Stumm, C. Sieber, 2002, Blood pressure.

Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.

Suzanne F. Jones, F. J. Ramos, J. Baselga, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging.

C. Schnell, R. Cozens, C. García-echeverría, 2008, Cancer research.

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).

R. Herrmann, H. Hawle, S. Dimitrijević, 2018, European journal of cancer.

Enzymatic Digestion of Adult Human Articular Cartilage Yields a Small Fraction of the Total Available Cells

I. Martin, M. Stumm, M. Heberer, 2003, Connective tissue research.

Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.

R. Greil, J. Baselga, H. Lane, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.

Michael Stumm, Kristian Pietras, C. Heldin, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Patupilone Induced Vascular Disruption in Orthotopic Rodent Tumor Models Detected by Magnetic Resonance Imaging and Interstitial Fluid Pressure

Michael Stumm, C. Schnell, J. Wood, 2005, Clinical Cancer Research.

Zonal gene expression in human colon assessed by laser microdissection (LMD) and quantitative real-time RT-PCR

D. Fabbro, M. Stumm, C. Sieber, 2001 .

Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts

M. Moran, Chris Orsi, D. Fabbro, 2004, Clinical Proteomics.

Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability

Didier Laurent, Michael Stumm, Claudia Weidensteiner, 2009, Clinical Cancer Research.

InducedVascular Disruption in Orthotopic Rodent TumorModels Detected byMagnetic Resonance Imaging and Interstitial Fluid Pressure

C. Schnell, S. Ferretti, T. O'reilly, 2005 .

Anti-Angiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET.

H. Lane, S. Ametamey, T. O'reilly, 2010, Translational oncology.

Validation of a postfixation tissue storage and transport medium to preserve histopathology and molecular pathology analyses (total and phosphoactivated proteins, and FISH).

T. O'reilly, U. Wagner, M. Stumm, 2012, American journal of clinical pathology.

A phase 1 first-in-human (FIH) dose-escalation (DE) study of the oral dual PI3K/mTOR inhibitor PQR309 in patients (pts) with advanced solid tumors: Final DE results.

R. Herrmann, S. Dimitrijević, A. Stathis, 2015 .

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.

H. Lane, N. Hynes, C. Brisken, 2008, Cancer Research.

Minimally invasive biomarkers for therapy monitoring.

H. Lane, C. Schnell, J. Wood, 2007, Ernst Schering Foundation symposium proceedings.

Quantified Tumor T1 Is a Generic Early-response Imaging Biomarker for Chemotherapy Reflecting Cell Viability Clinical Cancer Research

S. Ferretti, S. Ruetz, M. Stumm, 2022 .